RLAY — Relay Therapeutics, Inc. stock price, charts and financials

QT80Relay Therapeutics, Inc.

Relay Therapeutics, Inc. (NASDAQ: RLAY) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
20.00
+0.23+1.16%
OverviewShort InterestFilings
RLAYQT80Relay Therapeutics, Inc.·NASDAQ
20.00+1.16%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 2026424B5Prospectus
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
May 21, 2026424B5Prospectus
May 21, 20268-KCurrent report
May 19, 2026424B5Prospectus
#1 / 25 of 430
Page
▼
/ 18